George Doherty

3.0k total citations
16 papers, 405 citations indexed

About

George Doherty is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, George Doherty has authored 16 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Physiology. Recurrent topics in George Doherty's work include Peptidase Inhibition and Analysis (4 papers), Cell Adhesion Molecules Research (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). George Doherty is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Cell Adhesion Molecules Research (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). George Doherty collaborates with scholars based in United States and United Kingdom. George Doherty's co-authors include Barry M. Trost, William K. Hagmann, Richard A. Mumford, Gail Van Riper, Sharon Tong, Theodore M. Kamenecka, James D. Bergstrom, Gary Chrebet, Suzanne Mandala and Gan-Ju Shei and has published in prestigious journals such as Journal of the American Chemical Society, Blood and The Journal of Immunology.

In The Last Decade

George Doherty

16 papers receiving 400 citations

Peers

George Doherty

PHYSI

PHARM

Yasutaka Takase Japan

Graham J. Warrellow United Kingdom

Gary E. Aspnes United States

James J. Perkins United States

Joseph Eckman United States

Miguel Fau de Casa-Juana Spain

Jean Shearin United States

Lluı́s Pagès Spain

Mark Charles United Kingdom

Jeffrey Varnes United States

Yasutaka Takase Japan

George Doherty

283 ×1.2

250 ×1.6

61 ×1.2

PHYSI

19 ×0.4

68 ×1.6

PHARM

Citations per year, relative to George Doherty George Doherty (= 1×) peers Yasutaka Takase

Countries citing papers authored by George Doherty

Since Specialization

Citations

This map shows the geographic impact of George Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Doherty more than expected).

Fields of papers citing papers by George Doherty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Doherty. The network helps show where George Doherty may publish in the future.

Co-authorship network of co-authors of George Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of George Doherty. A scholar is included among the top collaborators of George Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Doherty. George Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Phillips, Darren C., Cory Alvey, Justin P. Ingram, et al.. (2024). Abbv-453: A Highly Potent and Selective Next Generation Small Molecule Inhibitor of BCL-2. Blood. 144(Supplement 1). 4966–4966. 1 indexed citations

Ortíz-Zapater, Elena, Dustin Bagley, George Doherty, et al.. (2023). The RNA binding proteins ZFP36L1 and ZFP36L2 are dysregulated in airway epithelium in human and a murine model of asthma. Frontiers in Cell and Developmental Biology. 11. 1241008–1241008. 4 indexed citations

Reilly, Regina M., Mark G. Anderson, Lora A. Tucker, et al.. (2023). Abstract 6311: ABBV-400: An ADC delivering a novel topoisomerase 1 inhibitor to c-Met-positive solid tumors. Cancer Research. 83(7_Supplement). 6311–6311. 7 indexed citations

Doherty, George, Pramila Bhatia, Timothy A. Vortherms, et al.. (2012). Discovery of diphenyl lactam derivatives as N-type calcium channel blockers. Bioorganic & Medicinal Chemistry Letters. 22(4). 1716–1718. 7 indexed citations

Scott, Victoria, Timothy A. Vortherms, Wende Niforatos, et al.. (2011). A-1048400 is a novel, orally active, state-dependent neuronal calcium channel blocker that produces dose-dependent antinociception without altering hemodynamic function in rats. Biochemical Pharmacology. 83(3). 406–418. 27 indexed citations

Cook, Adam, George Doherty, Kevin J. Hunt, et al.. (2009). Identification and characterization of a potent and selective antagonist of the prostaglandin D2 receptor (94.23). The Journal of Immunology. 182(Supplement_1). 94.23–94.23. 1 indexed citations

Yan, Lin, George Doherty, Jeffrey J. Hale, et al.. (2006). Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes. Bioorganic & Medicinal Chemistry Letters. 16(14). 3679–3683. 15 indexed citations

Hale, Jeffrey J., George Doherty, Sander G. Mills, et al.. (2004). Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(13). 3501–3505. 39 indexed citations

Hale, Jeffrey J., George Doherty, Sander G. Mills, et al.. (2004). The discovery of 3-(N-alkyl)aminopropylphosphonic acids as potent S1P receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(13). 3495–3499. 26 indexed citations

10.

Koo, Gloria C., Kashmira Shah, G J Ding, et al.. (2003). A Small Molecule Very Late Antigen–4 Antagonist Can Inhibit Ovalbumin-induced Lung Inflammation. American Journal of Respiratory and Critical Care Medicine. 167(10). 1400–1409. 36 indexed citations

11.

Doherty, George, Ginger X. Yang, Sharon Tong, et al.. (2003). N-Isonicotinoyl-(l)-4-aminophenylalanine derivatives as tight binding VLA-4 antagonists. Bioorganic & Medicinal Chemistry Letters. 13(11). 1891–1895. 11 indexed citations

12.

Doherty, George, Theodore M. Kamenecka, Gail Van Riper, et al.. (2002). N-Aryl 2,6-Dimethoxybiphenylalanine Analogues as VLA-4 Antagonists. Bioorganic & Medicinal Chemistry Letters. 12(5). 729–731. 44 indexed citations

13.

Yang, Ginger X., Linda Chang, Quang Truong, et al.. (2002). N-Tetrahydrofuroyl-(l)-phenylalanine derivatives as potent VLA-4 antagonists. Bioorganic & Medicinal Chemistry Letters. 12(11). 1497–1500. 23 indexed citations

14.

Doherty, George, Ginger X. Yang, Linda Chang, et al.. (2002). Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists. Bioorganic & Medicinal Chemistry Letters. 12(11). 1501–1505. 16 indexed citations

15.

Trost, Barry M. & George Doherty. (2000). ChemInform Abstract: An Asymmetric Synthesis of the Tricyclic Core (I) and a Formal Total Synthesis of Roseophilin (II) via an Enyne Metathesis.. ChemInform. 31(30). 1 indexed citations

16.

Trost, Barry M. & George Doherty. (2000). An Asymmetric Synthesis of the Tricyclic Core and a Formal Total Synthesis of Roseophilin via an Enyne Metathesis. Journal of the American Chemical Society. 122(16). 3801–3810. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact